These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
943 related articles for article (PubMed ID: 26158151)
1. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer. Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151 [TBL] [Abstract][Full Text] [Related]
2. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer. Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531 [TBL] [Abstract][Full Text] [Related]
4. Clinical study of cisplatin hyperthermic intraperitoneal perfusion chemotherapy in combination with docetaxel, 5-flourouracil and leucovorin intravenous chemotherapy for the treatment of advanced-stage gastric carcinoma. Zhibing W; Qinghua D; Shenglin M; Ke Z; Kan W; Xiadong L; Pengjun Z; Ruzhen Z Hepatogastroenterology; 2013; 60(125):989-94. PubMed ID: 23598741 [TBL] [Abstract][Full Text] [Related]
5. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer. Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann JT; Baronius W; Hempel V; Kanz L; Bokemeyer C Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461 [TBL] [Abstract][Full Text] [Related]
6. A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer. Kollmannsberger C; Quietzsch D; Haag C; Lingenfelser T; Schroeder M; Hartmann JT; Baronius W; Hempel V; Clemens M; Kanz L; Bokemeyer C Br J Cancer; 2000 Aug; 83(4):458-62. PubMed ID: 10945491 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706 [TBL] [Abstract][Full Text] [Related]
8. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer. Gu Y; Shu Y; Xu Q Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761 [TBL] [Abstract][Full Text] [Related]
9. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
10. [A case of advanced gastric cancer treated effectively with neo-adjuvant chemotherapy using l-leucovorin and 5-FU]. Terada J; Mizuno I; Kobayashi K; Ueda T; Mohri N; Inagaki H; Manabe T Gan To Kagaku Ryoho; 1995 Oct; 22(12):1835-8. PubMed ID: 7574818 [TBL] [Abstract][Full Text] [Related]
11. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Brenner B; Shah MA; Karpeh MS; Gonen M; Brennan MF; Coit DG; Klimstra DS; Tang LH; Kelsen DP Ann Oncol; 2006 Sep; 17(9):1404-11. PubMed ID: 16788003 [TBL] [Abstract][Full Text] [Related]
12. Postoperative chemoradiotherapy for advanced gastric cancer after D2 gastrectomy. Deng X; Jin X; Xue S; Zhang X; Su H; Zhang P; Xie C Hepatogastroenterology; 2014; 61(133):1472-7. PubMed ID: 25436327 [TBL] [Abstract][Full Text] [Related]
13. Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative resection of gastric adenocarcinoma. Zhang XL; Shi HJ; Cui SZ; Tang YQ; Ba MC Eur J Surg Oncol; 2011 Jun; 37(6):466-72. PubMed ID: 21414740 [TBL] [Abstract][Full Text] [Related]
14. Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program. Leichman L; Silberman H; Leichman CG; Spears CP; Ray M; Muggia FM; Kiyabu M; Radin R; Laine L; Stain S J Clin Oncol; 1992 Dec; 10(12):1933-42. PubMed ID: 1453207 [TBL] [Abstract][Full Text] [Related]
15. A phase II study of irinotecan, continuous 5-fluorouracil, and leucovorin (FOLFIRI) combination chemotherapy for patients with recurrent or metastatic gastric cancer previously treated with a fluoropyrimidine-based regimen. Kim SH; Lee GW; Go SI; Cho SH; Kim HJ; Kim HG; Kang JH Am J Clin Oncol; 2010 Dec; 33(6):572-6. PubMed ID: 20042971 [TBL] [Abstract][Full Text] [Related]
16. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Chipponi J; Huguier M; Pezet D; Basso N; Hay JM; Quandalle P; Jaeck D; Fagniez PL; Gainant A Am J Surg; 2004 Mar; 187(3):440-5. PubMed ID: 15006580 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study. Ott K; Sendler A; Becker K; Dittler HJ; Helmberger H; Busch R; Kollmannsberger C; Siewert JR; Fink U Gastric Cancer; 2003; 6(3):159-67. PubMed ID: 14520529 [TBL] [Abstract][Full Text] [Related]
19. Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer. Atiq OT; Kelsen DP; Shiu MH; Saltz L; Tong W; Niedzwiecki D; Trochanowski B; Lin S; Toomasi F; Brennan M J Clin Oncol; 1993 Mar; 11(3):425-33. PubMed ID: 8445416 [TBL] [Abstract][Full Text] [Related]
20. Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer. Wang F; Wang Z; Zhou N; An X; Xu R; He Y; Li Y Am J Clin Oncol; 2011 Aug; 34(4):401-5. PubMed ID: 21791984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]